Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Using simple forms can improve stroke care

09.08.2005


Using standardized forms at the time stroke patients are admitted to and discharged from the hospital can improve care, according to a study published in the August 9, 2005 issue of Neurology, the scientific journal of the American Academy of Neurology.



Studies have shown that several treatments for stroke patients reduce the amount of disability, complications and the risk of having another stroke. The treatments are for people with ischemic stroke, which is the most common type, caused by blocked or reduced blood flow to the brain. The treatments are also recommended in guidelines from the American Academy of Neurology and other organizations. Despite this evidence and recommendations, these treatments are not used as often as they could be due to oversight or lack of awareness.

"Care of stroke patients is complicated, and the evidence is growing rapidly," explained S. Claiborne Johnston, MD, PhD, principal investigator for the study and a neurologist and director of the Stroke Service at University of California, San Francisco. "It’s difficult for busy clinicians to keep up with proven best practices, and things can fall through the cracks."


In an effort to increase the use of these treatments, six California hospitals in the study developed standardized forms for use when stroke patients were admitted to and discharged from the hospital. The forms included the recommended treatments. The treatments are: using a clot-busting treatment within three hours of the start of the stroke; preventive treatment for blood clots in the leg veins; drugs that prevent blood clots from forming within 48 hours of arrival at the hospital and at discharge; cholesterol-lowering drugs at discharge; and smoking cessation counseling.

If the treatment was not used, the forms included boxes to check for acceptable reasons for not using the treatment, such as not using a clot-busting drug for a patient who arrived at the hospital more than three hours after the first symptoms or not using cholesterol-lowering drugs for a patient who already had low cholesterol.

The treatment stroke patients received in the year after the new forms were implemented was compared to the treatment they received in the year before the forms were implemented. During that time, 413 patients were treated in the six hospitals.

Overall, patients were more likely to receive optimal treatment after the forms were implemented than before. Optimal treatment was defined as receiving all of the recommended treatments unless there was an appropriate reason not to receive a treatment.

After the forms were implemented, 63 percent of patients received optimal treatment. In the year before the forms were implemented, 44 percent of patients received optimal treatment.

One additional hospital started the study, but did not implement the forms due to an administrative delay. In that hospital, there was no change in the percentage of patients who received optimal treatment from the first year to the second year.

The rate of optimal treatment improved for these treatments: preventive treatment for blood clots in the leg veins; drugs that prevent blood clots from forming within 48 hours of arrival at the hospital and at discharge; and cholesterol-lowering drugs at discharge.

Increasing the use of clot-busting drugs is difficult, according to Dr. Johnston, because most patients do not come to the hospital soon enough. "People need to know that stroke is an emergency," he said. "It’s a brain attack. If you or someone you know has signs of stroke, call 911 immediately. We can only use one of the most effective treatments if it can be given within three hours after the first symptom starts."

Johnston said the study shows that it is feasible to significantly improve stroke treatment. However, he noted that the researchers cannot be certain that use of the forms led to the improvement. "All hospitals were aware that these measures were being monitored, and there were many discussions about the treatments," he said. "It’s not possible to know whether simply measuring outcomes and providing feedback would have produced similar improvements in care."

Johnston also noted that increased advertising for cholesterol-lowering drugs could have led to increased use that was unrelated to the stroke forms.

"Additional studies are needed to confirm these results," Johnston said. "Regardless, the study shows that we need to do better but that we can make it happen fairly painlessly."

Robin Stinnett | EurekAlert!
Further information:
http://www.aan.com

More articles from Studies and Analyses:

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

nachricht Urbanization to convert 300,000 km2 of prime croplands
27.12.2016 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>